Cutler Group LP Amgen Inc Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Amgen Inc stock. As of the latest transaction made, Cutler Group LP holds 32 shares of AMGN stock, worth $8,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 100 68.0%

Holding current value

$8,960

Previous $28,000 67.86%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$268.87 - $324.56 $18,283 - $22,070	-68 Reduced 68.0%	32 $9,000
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $23,013 - $25,961	-90 Reduced 47.37%	100 $28,000
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $45,916 - $57,006	-210 Reduced 52.5%	190 $51,000
Q2 2023 Jul 18, 2023	BUY	$214.27 - $253.37 $85,708 - $101,348	400 New	400 $88,000
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $1.46 Million - $1.86 Million	6,375 Added 118.98%	11,733 $3.08 Million
Q3 2022 Oct 25, 2022	SELL	$224.46 - $253.15 $1.72 Million - $1.94 Million	-7,669 Reduced 58.87%	5,358 $1.21 Million
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $3.01 Million - $3.34 Million	13,027 New	13,027 $3.17 Million
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $893,187 - $1.04 Million	-4,025 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $865,520 - $1.03 Million	4,000 Added 16000.0%	4,025 $925,000
Q3 2020 Oct 27, 2020	SELL	$234.65 - $260.95 $8,682 - $9,655	-37 Reduced 59.68%	25 $6,000
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $24,330 - $29,857	-123 Reduced 66.49%	62 $14,000
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $421,370 - $541,606	-2,227 Reduced 92.33%	185 $44,000
Q3 2019 Oct 28, 2019	BUY	$174.11 - $208.62 $253,852 - $304,167	1,458 Added 152.83%	2,412 $466,000
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $656,738 - $740,288	-3,631 Reduced 79.19%	954 $181,000
Q4 2018 Feb 05, 2019	BUY	$178.4 - $208.25 $89,200 - $104,125	500 Added 12.24%	4,585 $892,000
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $426,167 - $480,446	2,300 Added 128.85%	4,085 $846,000
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $2.24 Million - $2.51 Million	-13,470 Reduced 88.3%	1,785 $329,000
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $145,540 - $170,082	859 Added 5.97%	15,255 $2.6 Million
Q4 2017 Jan 17, 2018	SELL	$168.79 - $188.59 $1.02 Million - $1.14 Million	-6,021 Reduced 29.49%	14,396 $2.5 Million
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $3.42 Million - $3.9 Million	20,417	20,417 $3.81 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account